| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/02/2002 | CA2424475A1 Method for the treatment of neurological and neuropsychological disorders |
| 05/02/2002 | CA2421885A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 05/02/2002 | CA2420164A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
| 05/01/2002 | CN1347420A Growth hormone secretagogues |
| 05/01/2002 | CN1347418A Novel nucleosides and oligonucleotide analogues |
| 05/01/2002 | CN1347416A Substd. 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases |
| 05/01/2002 | CN1347415A Tricyclic pyridine N-oxides vasopressin agonists |
| 05/01/2002 | CN1347414A Triazole compounds with dopamine-D3-receptor affinity |
| 05/01/2002 | CN1347411A Sulfonamide derivs. having oxadiazole rings |
| 05/01/2002 | CN1347408A Use of maduraphthalazine derivs. as inhibitors of pro-inflammatory cytokins |
| 05/01/2002 | CN1347326A BAFF, inhibitors thereof and their use in modulation of B-cell response |
| 05/01/2002 | CN1347325A Novel amide derivs. as growth hormone secretagogues |
| 05/01/2002 | CN1347323A Chemical compounds |
| 05/01/2002 | CN1347322A Chemical compounds |
| 05/01/2002 | CN1347321A Use of vasopeptidase inhibitors to treat angina pectoris |
| 05/01/2002 | CN1347318A Inhibitors of IMPDH enzyme |
| 05/01/2002 | CN1347317A Remedies |
| 05/01/2002 | CN1347309A Skin care compositions contg. combination of skin care actives |
| 05/01/2002 | CN1346831A Purified polypeptide with bioactivity and medicine prepared from it for promoting growth and development of animal's nerve cells and suppressing their apotosis |
| 05/01/2002 | CN1346830A Novel 2,4-dioxopyrrolidone and 2,4-dioxotetrahydro-furan derivs. and medicine contg. them as active component |
| 05/01/2002 | CN1346675A Chinese patent medicine for treating paraplegia |
| 05/01/2002 | CN1346641A Freezed dried centipede |
| 05/01/2002 | CN1083838C Novel imidazole derivs., method for preparing same, use as medicine, and pharmaceutical compositions contg. same |
| 05/01/2002 | CN1083834C Nipecotic acid derivs. as antithrombic compounds |
| 05/01/2002 | CN1083831C Novel tricyclic compounds and drug compositions contg. same |
| 05/01/2002 | CN1083830C Substd. benzamidines, their production and their use as medicaments |
| 05/01/2002 | CN1083716C Menstruum for penicillin anaphylaxis intracutaneous test |
| 04/30/2002 | US6380430 Biphenyl derivatives |
| 04/30/2002 | US6380408 Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1α, 25-dihydroxy vitamin D3 |
| 04/30/2002 | US6380405 Taxane prodrugs |
| 04/30/2002 | US6380396 Chemical intermediates for antiinflammatory agents |
| 04/30/2002 | US6380394 Anticancer agents |
| 04/30/2002 | US6380374 Isolated nucleic acid; culture product |
| 04/30/2002 | US6380338 Polymers for cosmetic formulations |
| 04/30/2002 | US6380261 Administering to retina antagonist of the nmda receptor-channel complex for therapy of proliferative vitreoretinopathy resulting from penetrating trauma, retinal tear, traction detachment, vitrectomy or intraocular surgery |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380257 Used as glucose-6-phosphate translocase inhibitors and can be used in therapy of diabetes mellitus |
| 04/30/2002 | US6380255 Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
| 04/30/2002 | US6380244 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 04/30/2002 | US6380242 For diagnosis and therapy of central nervous system conditions |
| 04/30/2002 | US6380239 For therapy of arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, inflammatory bowel disease, crohn's disease, ulcerative colitis, systemic lupus erythrematosis, scleroderma, aphthous ulcers, asthma |
| 04/30/2002 | US6380235 Useful as progesterone receptor agonists and antagonists, used for contraception, in therapy of fibroids, endometriosis, breast, uterine, ovarian and prostate cancer, and post menopausal hormone replacement therapy |
| 04/30/2002 | US6380230 For therapy of dyskinesia, obesity, irritable bowel syndrome, diseases whose treatment requires stimulation of the cholecystokinin cck-a receptors |
| 04/30/2002 | US6380229 Useful for therapy and prophylaxis of hyperlipidemia and related complications |
| 04/30/2002 | US6380227 Fermentative preparation process for and crystal forms of cytostatics |
| 04/30/2002 | US6380226 For therapy of migraine, cluster headache, chronic paroxysmal hemicrania or headache associated with a vascular disorder, depression, anxiety, an eating disorder, obesity, drug abuse, hypertension and emesis |
| 04/30/2002 | US6380224 For therapy of eating disorders, obesity, bulimia nervosa, diabetes, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders, depression and anxiety |
| 04/30/2002 | US6380223 For therapy of diseases, such as obesity, diabetes, inflammation |
| 04/30/2002 | US6380221 Ortho-anthranilamide derivatives as anti-coagulants |
| 04/30/2002 | US6380220 Therapy of neurodegenerative diseases and neuronal injuries which are casued by ischemia, trauma or massive hemorrhages |
| 04/30/2002 | US6380218 For therapy of respiratory, allergic, and inflammatory disorders comprising asthma, chronic obstructive pulmonary disease, acute respiratory disease syndrome, pulmonary hypersensitivity, and allergic rhinitis in a mammal |
| 04/30/2002 | US6380211 For treating diabetes |
| 04/30/2002 | US6380207 1h-(1)benzopyrano(3,4-f) quinoline derivatives |
| 04/30/2002 | US6380205 2-cyclohexyl quinazoline NMDA/NR2B antagonists |
| 04/30/2002 | US6380204 Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist activity |
| 04/30/2002 | US6380199 Treatment of attention deficit hyperactivity disorder |
| 04/30/2002 | US6380195 Including (methylenedioxyphenyl)cyclopenteno(1,2-b)pyridine derivatives |
| 04/30/2002 | US6380191 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 04/30/2002 | US6380190 Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and methods for use thererof |
| 04/30/2002 | US6380186 Psychotherapeutic agents |
| 04/30/2002 | US6380170 Nucleic acid construct for the cell cycle regulated expression of structural genes |
| 04/30/2002 | US6380160 Gp130 lacking the transmembrane domain |
| 04/30/2002 | US6379931 Derived from spacer reagent 3-(4,4'-dimethoxytrityloxy)propane-1-((2-cyanoethyl)-(n,n-diisopropyl)) -phosphoramidite; use treating viral and rna-mediated diseases such as hiv |
| 04/30/2002 | US6379927 Retinoblastoma fusion proteins |
| 04/30/2002 | US6379913 A polypeptide encoding an amino acid sequence; prevention and therapy for diabetes, inflammatory glomerulonephritis, ischemis renal failure, artherosclerosis, coronary vasoconstriction and ischemic heart disease |
| 04/30/2002 | US6379699 Liposome having attached target-binding moiety and artherosclerotic plaque interacting moiety |
| 04/30/2002 | US6379685 Acidic aqueous chlorite teat dip with improved emollient providing shelf life, sanitizing capacity and tissue protection |
| 04/30/2002 | US6379649 Useful for diagnosis and treatment, including radiotherapy, of disorders that are characterized by an abnormal density of peripheral benzodiazepine receptors; nerve system disporders |
| 04/30/2002 | US6379401 Alkaline agent, peroxygen salt and polymer thickeners and nonionic surfactant |
| 04/30/2002 | CA2360049A1 Assays for identifying phosphatase inhibitors |
| 04/30/2002 | CA2241827C Novel substituted 4-(1h-benzimidazol-2-yl)¬1,4|diazepanes useful for the treatment of allergic diseases |
| 04/30/2002 | CA2221417C Anhydrous alendronate monosodium salt formulations |
| 04/30/2002 | CA2200771C New silicated salicylic acid derivatives with desquamative properties |
| 04/30/2002 | CA2194976C Wound healing agent |
| 04/30/2002 | CA2172114C New thiophene compounds, process for preparing the same and pharmaceutical compositions containing them |
| 04/30/2002 | CA2151045C Platelet-activating factor acetylhydrolase |
| 04/30/2002 | CA2054111C Novel inhibitory peptides |
| 04/30/2002 | CA2047997C Antibiotic, balhimycin, a process for its production and its use as pharmaceutical |
| 04/30/2002 | CA2042937C Treatment of ocular hypertension with a synergistic combination |
| 04/30/2002 | CA2042936C Treatment of ocular hypertension with a synergistic combination for ophthalmic use |
| 04/27/2002 | CA2360015A1 Angiotensin i-converting enzyme inhibitory substance |
| 04/26/2002 | CA2359877A1 Combination treatment for dementia or cognitive deficits associated with alzheimer's disease and parkinson's disease |
| 04/26/2002 | CA2324631A1 A substance or composition for the treatment of cancer |
| 04/25/2002 | WO2002033119A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 04/25/2002 | WO2002033100A2 Regulation of human adenylate cyclase, type iv |
| 04/25/2002 | WO2002033099A2 Human kinases |
| 04/25/2002 | WO2002033095A2 Regulation of human serine-threonine protein kinase |
| 04/25/2002 | WO2002033086A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | WO2002033079A2 Human g-protein coupled receptor and uses thereof |
| 04/25/2002 | WO2002033071A1 Survivin-like polypeptides and dnas thereof |
| 04/25/2002 | WO2002032961A2 Novel polypeptides and nucleic acids encoding same |
| 04/25/2002 | WO2002032960A2 Methods of selecting compounds for modulation of bladder function |
| 04/25/2002 | WO2002032958A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
| 04/25/2002 | WO2002032953A2 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | WO2002032940A2 Osteopontin-coated surfaces and methods of use |
| 04/25/2002 | WO2002032932A2 Urotensin-ii agonists and antagonists |
| 04/25/2002 | WO2002032904A1 New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents |
| 04/25/2002 | WO2002032901A2 Bridged piperazine derivatives |
| 04/25/2002 | WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 04/25/2002 | WO2002032894A1 Substituted imidazoles useful in the treatment of inflammatory diseases |